Takeda forecasts ¥193 billion annual operating loss on Shire deal

Takeda Pharmaceutical Co forecast on Tuesday it would have an operating loss in the current financial year, as it books costs associated with the multibillion-dollar Shire deal. Japan’s…

More Headlines

Follow worldbiztoday on Twitter

US Stocks